# BioFlorida

Type: Company

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/bioflorida
Canonical HTML page: https://getstartupbrief.com/entity/bioflorida

## Timeline

- **2026-Q4**: Clinical Milestones — Anticipated updates on Phase 1/2 glioblastoma trial progress.
- **2026-03-24**: BioFlorida Showcase — Cornerstone Session presentation on Innovation in South Florida.
- **2026-03-10**: Investival Showcase — Presentation at the South Florida Rising Life Science Hub event.
- **2026-02-15**: National Engagement — Presented at BioCom California and BIO Investor Forum to engage global partners.

## Recent coverage (1 stories)

### Myosin Therapeutics Showcases First-in-Class Glioblastoma Therapy in Florida
2026-03-10 01:08:52 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Myosin Therapeutics has been selected to present its novel nanomotor-dependency platform at two major South Florida life sciences conferences this March. The company is advancing MT-125, a first-in-class inhibitor currently in Phase 1/2 trials for glioblastoma, as it seeks to capitalize on South Florida's emergence as a biotechnology hub.
Full story: https://getstartupbrief.com/story/myosin-therapeutics-glioblastoma-therapy-florida-showcase

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.